Novel Anti-Cancer Drugs

There are significant challenges to global drug development in the recent years.Despite vast research and development in the field of oncology, the translation of research advance into medicines that substantially improve the treatment of many cancers is witnessing slow growth. What could be the key challenges in anticancer drug development, and how can they be addressed? Some of the major threats the pharmaceutical industry is now facing, include the increase in the cost of research and development without an attenuated improvement in productivity (i.e, the number of agents approved), the longer duration of development without a corresponding decrease in development risk; and the increasingly conservative regulatory climate coupled with the increasingly difficult reimbursement setting. Cancer Science-2018 provides a global platform to share developments concerned to Anti-cancer drugs.